Literature DB >> 23847252

Model-based iterative reconstruction and adaptive statistical iterative reconstruction techniques in abdominal CT: comparison of image quality in the detection of colorectal liver metastases.

David Volders1, Alain Bols, Marc Haspeslagh, Kenneth Coenegrachts.   

Abstract

PURPOSE: To prospectively evaluate dose reduction and image quality characteristics of abdominal computed tomographic (CT) scans reconstructed with model-based iterative reconstruction (MBIR) compared with adaptive statistical iterative reconstruction (ASIR) in oncology patients with colorectal liver metastases.
MATERIALS AND METHODS: The study complied with HIPAA guidelines and was approved by the ethics committee of the institutional review board. All patients gave written informed consent. Fifty-one patients with colorectal liver metastases underwent body CT (thorax and abdomen) with a 64-section multidetector unit. With a radiation dose reduction by 2.36 mGy compared to standard of care CT with ASIR 50% (radiation dose, 7.54 mGy), MBIR can provide diagnostically acceptable CT scans without compromising image quality. Two radiologists independently assessed randomized images in a blinded manner. Imaging sets were compared for lesion detection, lesion conspicuity, overall image quality, and signal-to-noise ratio with a paired sample t test. Inter- and intraobserver agreement was assessed with the Cohen κ.
RESULTS: The mean volume CT dose index was 5.18 mGy ± 0.76, mean dose-length product 374 mGy · cm ± 63.47, mean effective diameter 29.38 cm ± 3.46, and mean size-specific dose estimate 6.52 mGy ± 0.73. In small liver lesions (<10 mm), detection and conspicuity were significantly higher with MBIR than with ASIR for both right (t = 3.245, P = .004 and t = 2.696, P = .013, respectively) and left (t = 2.390, P = .038 and t = 2.283, P = .046) liver lobes. Subjective image noise (t = 4.506, P < .001), artifacts (t = 3.479, P = .001), and diagnostic confidence (t = 2.643, P = .011) were significantly better with MBIR than with ASIR.
CONCLUSION: MBIR performed better than ASIR 50% at providing diagnostically acceptable CT scans without compromising image quality and in the detection of colorectal liver metastases. RSNA, 2013

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23847252     DOI: 10.1148/radiology.13130002

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  38 in total

1.  Comparison of the image qualities of filtered back-projection, adaptive statistical iterative reconstruction, and model-based iterative reconstruction for CT venography at 80 kVp.

Authors:  Jin Hyeok Kim; Ki Seok Choo; Tae Yong Moon; Jun Woo Lee; Ung Bae Jeon; Tae Un Kim; Jae Yeon Hwang; Myeong-Ja Yun; Dong Wook Jeong; Soo Jin Lim
Journal:  Eur Radiol       Date:  2015-10-20       Impact factor: 5.315

2.  Prospective trial of the detection of urolithiasis on ultralow dose (sub mSv) noncontrast computerized tomography: direct comparison against routine low dose reference standard.

Authors:  B Dustin Pooler; Meghan G Lubner; David H Kim; Eva M Ryckman; Sri Sivalingam; Jie Tang; Stephen Y Nakada; Guang-Hong Chen; Perry J Pickhardt
Journal:  J Urol       Date:  2014-05-21       Impact factor: 7.450

3.  Assessment of sub-milli-sievert abdominal computed tomography with iterative reconstruction techniques of different vendors.

Authors:  Atul Padole; Nisha Sainani; Diego Lira; Ranish Deedar Ali Khawaja; Sarvenaz Pourjabbar; Roberto Lo Gullo; Alexi Otrakji; Mannudeep K Kalra
Journal:  World J Radiol       Date:  2016-06-28

Review 4.  Dose reduction in pediatric abdominal CT: use of iterative reconstruction techniques across different CT platforms.

Authors:  Ranish Deedar Ali Khawaja; Sarabjeet Singh; Alexi Otrakji; Atul Padole; Ruth Lim; Katherine Nimkin; Sjirk Westra; Mannudeep K Kalra; Michael S Gee
Journal:  Pediatr Radiol       Date:  2014-11-27

5.  Impact of model-based iterative reconstruction on low-contrast lesion detection and image quality in abdominal CT: a 12-reader-based comparative phantom study with filtered back projection at different tube voltages.

Authors:  André Euler; Bram Stieltjes; Zsolt Szucs-Farkas; Reto Eichenberger; Clemens Reisinger; Anna Hirschmann; Caroline Zaehringer; Achim Kircher; Matthias Streif; Sabine Bucher; David Buergler; Luigia D'Errico; Sebastién Kopp; Markus Wilhelm; Sebastian T Schindera
Journal:  Eur Radiol       Date:  2017-04-03       Impact factor: 5.315

6.  Full model-based iterative reconstruction (MBIR) in abdominal CT increases objective image quality, but decreases subjective acceptance.

Authors:  Gautier Laurent; Nicolas Villani; Gabriela Hossu; Aymeric Rauch; Alain Noël; Alain Blum; Pedro Augusto Gondim Teixeira
Journal:  Eur Radiol       Date:  2019-01-30       Impact factor: 5.315

7.  Iterative algorithms for metal artifact reduction in children with orthopedic prostheses: preliminary results.

Authors:  Seema Toso; Meryle Laurent; Elise Dupuis Lozeron; Pauline Brindel; Marirosa Cristallo Lacalamita; Sylviane Hanquinet
Journal:  Pediatr Radiol       Date:  2018-07-28

Review 8.  Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT.

Authors:  Shigeyoshi Kijima; Takahiro Sasaki; Koichi Nagata; Kenichi Utano; Alan T Lefor; Hideharu Sugimoto
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT.

Authors:  Corey T Jensen; Nicolaus A Wagner-Bartak; Lan N Vu; Xinming Liu; Bharat Raval; David Martinez; Wei Wei; Yuan Cheng; Ehsan Samei; Shiva Gupta
Journal:  Radiology       Date:  2018-11-27       Impact factor: 11.105

10.  Evaluation of Abdominal Computed Tomography Image Quality Using a New Version of Vendor-Specific Model-Based Iterative Reconstruction.

Authors:  Corey T Jensen; Morgan E Telesmanich; Nicolaus A Wagner-Bartak; Xinming Liu; John Rong; Janio Szklaruk; Aliya Qayyum; Wei Wei; Adam G Chandler; Eric P Tamm
Journal:  J Comput Assist Tomogr       Date:  2017-01       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.